Logo image of KEQU

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

NASDAQ:KEQU - Nasdaq - US4928541048 - Common Stock - Currency: USD

56.67  +1.87 (+3.41%)

After market: 56.67 0 (0%)

Fundamental Rating

4

Overall KEQU gets a fundamental rating of 4 out of 10. We evaluated KEQU against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

KEQU had positive earnings in the past year.
KEQU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

KEQU's Return On Assets of 9.29% is amongst the best of the industry. KEQU outperforms 92.51% of its industry peers.
KEQU has a Return On Equity of 28.92%. This is amongst the best in the industry. KEQU outperforms 97.86% of its industry peers.
KEQU has a better Return On Invested Capital (8.35%) than 88.77% of its industry peers.
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROIC 8.35%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

KEQU has a better Profit Margin (7.99%) than 81.82% of its industry peers.
KEQU's Profit Margin has improved in the last couple of years.
KEQU has a Operating Margin of 6.73%. This is in the better half of the industry: KEQU outperforms 74.87% of its industry peers.
KEQU's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 27.02%, KEQU is not doing good in the industry: 75.94% of the companies in the same industry are doing better.
KEQU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

4

2. Health

2.1 Basic Checks

KEQU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for KEQU has been increased compared to 1 year ago.
KEQU has more shares outstanding than it did 5 years ago.
KEQU has a better debt/assets ratio than last year.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.95 indicates that KEQU is not a great score, but indicates only limited risk for bankruptcy at the moment.
KEQU has a Altman-Z score of 2.95. This is in the better half of the industry: KEQU outperforms 68.45% of its industry peers.
KEQU has a debt to FCF ratio of 17.20. This is a negative value and a sign of low solvency as KEQU would need 17.20 years to pay back of all of its debts.
KEQU has a better Debt to FCF ratio (17.20) than 72.19% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that KEQU has dependencies on debt financing.
KEQU has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: KEQU underperforms 78.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Altman-Z 2.95
ROIC/WACC1
WACC8.37%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 2.16 indicates that KEQU has no problem at all paying its short term obligations.
The Current ratio of KEQU (2.16) is worse than 61.50% of its industry peers.
A Quick Ratio of 1.54 indicates that KEQU should not have too much problems paying its short term obligations.
KEQU's Quick ratio of 1.54 is in line compared to the rest of the industry. KEQU outperforms 43.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.54
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.96%.
The earnings per share for KEQU have been decreasing by -18.78% on average. This is quite bad
Looking at the last year, KEQU shows a decrease in Revenue. The Revenue has decreased by -7.27% in the last year.
The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%25.81%
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%36.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 66.67, which means the current valuation is very expensive for KEQU.
66.84% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.98. KEQU is valued rather expensively when compared to this.
Industry RankSector Rank
PE 66.67
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

88.24% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
KEQU's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. KEQU is cheaper than 77.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.5
EV/EBITDA 11.58
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KEQU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (6/27/2025, 8:00:02 PM)

After market: 56.67 0 (0%)

56.67

+1.87 (+3.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-25 2025-06-25/amc
Earnings (Next)09-09 2025-09-09
Inst Owners42.22%
Inst Owner Change-4.72%
Ins Owners15.99%
Ins Owner Change-1.86%
Market Cap161.51M
Analysts82.86
Price TargetN/A
Short Float %2.25%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 66.67
Fwd PE N/A
P/S 0.73
P/FCF 41.5
P/OCF 24.77
P/B 2.66
P/tB 5.68
EV/EBITDA 11.58
EPS(TTM)0.85
EY1.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.37
FCFY2.41%
OCF(TTM)2.29
OCFY4.04%
SpS77.2
BVpS21.33
TBVpS9.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROCE 10.66%
ROIC 8.35%
ROICexc 8.96%
ROICexgc 11.91%
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
FCFM 1.77%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y44.49%
ROICexc growth 3YN/A
ROICexc growth 5Y44.49%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
F-Score5
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Debt/EBITDA 3.35
Cap/Depr 65.66%
Cap/Sales 1.19%
Interest Coverage 250
Cash Conversion 34.65%
Profit Quality 22.14%
Current Ratio 2.16
Quick Ratio 1.54
Altman-Z 2.95
F-Score5
WACC8.37%
ROIC/WACC1
Cap/Depr(3y)117.83%
Cap/Depr(5y)107.18%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%25.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%36.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.94%
EBIT growth 3YN/A
EBIT growth 5Y54.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y130.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.01%
OCF growth 3Y178.06%
OCF growth 5Y51.03%